EA
MGNX icon

Emerald Advisers’s MacroGenics MGNX Stock Holding History

Emerald Advisers’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-445,295
Closed -$8.23M – 258
2017
Q3 		$8.23M Sell
445,295
-9,050
-2% -$157K 0.33% 105
2017
Q2 		$7.96M Sell
454,345
-22,915
-5% -$437K 0.33% 99
2017
Q1 		$8.88M Sell
477,260
-5,575
-1% -$108K 0.36% 100
2016
Q4 		$9.87M Buy
482,835
+72,893
+18% +$1.83M 0.42% 89
2016
Q3 		$12.3M Buy
409,942
+48,799
+14% +$1.45M 0.55% 73
2016
Q2 		$9.75M Sell
361,143
-151,753
-30% -$3.42M 0.47% 77
2016
Q1 		$9.62M Buy
512,896
+69,940
+16% +$1.33M 0.47% 71
2015
Q4 		$13.7M Buy
442,956
+64,698
+17% +$1.97M 0.65% 56
2015
Q3 		$8.1M Sell
378,258
-2,601
-0.7% -$81.6K 0.42% 79
2015
Q2 		$14.5M Buy
380,859
+1,890
+0.5% +$62.1K 0.69% 46
2015
Q1 		$12.1M Buy
378,969
+3,740
+1% +$127K 0.61% 51
2014
Q4 		$13.2M Buy
375,229
+143,050
+62% +$3.57M 0.7% 39
2014
Q3 		$4.85M Buy
232,179
+2,800
+1% +$57.9K 0.29% 118
2014
Q2 		$4.98M Buy
229,379
+2,460
+1% +$51.7K 0.28% 125
2014
Q1 		$6.32M Buy
226,919
+17,490
+8% +$618K 0.36% 103
2013
Q4 		$5.75M Buy
+209,429
New +$5.48M 0.31% 112

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Advisers's MGNX Position: Q4 2017 in Review

Emerald Advisers sold out of MacroGenics (MGNX) in Q4 2017, closing a stake of 445,295 shares — an estimated $8.23M sold.

Emerald Advisers first reported a position in MGNX in Q4 2013 and held it in 16 quarters. The position peaked at $14.5M in Q2 2015. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

  • Emerald Advisers reported no remaining MacroGenics position as of Q4 2017 after selling out during the quarter.
  • Emerald Advisers sold 445,295 MacroGenics shares in Q4 2017, an estimated $8.23M.
  • Emerald Advisers first reported a position in MacroGenics in Q4 2013 and held it in 16 quarters.
  • Emerald Advisers's MacroGenics position peaked at $14.5M in Q2 2015.
  • 119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Emerald Advisers's 13F filing for Q4 2017, filed 5 Feb 2018.